These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17588213)

  • 1. Medication use and disease management of type 2 diabetes in Belgium.
    Mehuys E; De Bolle L; Van Bortel L; Annemans L; Van Tongelen I; Remon JP; Giri M
    Pharm World Sci; 2008 Jan; 30(1):51-6. PubMed ID: 17588213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial.
    Mehuys E; Van Bortel L; De Bolle L; Van Tongelen I; Annemans L; Remon JP; Giri M
    J Clin Pharm Ther; 2011 Oct; 36(5):602-13. PubMed ID: 21143256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial.
    Suppapitiporn S; Chindavijak B; Onsanit S
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S134-41. PubMed ID: 16623018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of simulated patients to assess diabetes and asthma counseling practices among community pharmacists in Qatar.
    Paravattil B; Kheir N; Yousif A
    Int J Clin Pharm; 2017 Aug; 39(4):759-768. PubMed ID: 28466396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes.
    Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
    Diabetologia; 2015 Oct; 58(10):2247-53. PubMed ID: 26277380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes Medication Assistance Service: the pharmacist's role in supporting patient self-management of type 2 diabetes (T2DM) in Australia.
    Mitchell B; Armour C; Lee M; Song YJ; Stewart K; Peterson G; Hughes J; Smith L; Krass I
    Patient Educ Couns; 2011 Jun; 83(3):288-94. PubMed ID: 21616627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication adherence program: adherence challenges and interventions in type 2 diabetes.
    Odegard PS; Carpinito G; Christensen DB
    J Am Pharm Assoc (2003); 2013; 53(3):267-72. PubMed ID: 23699675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-reported medication and lifestyle adherence in Hungarian patients with Type 2 diabetes.
    Hankó B; Kázmér M; Kumli P; Hrágyel Z; Samu A; Vincze Z; Zelkó R
    Pharm World Sci; 2007 Apr; 29(2):58-66. PubMed ID: 17187222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
    Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
    Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' Attitudes and Role in Diabetes Management in Bosnia and Herzegovina.
    Catic T; Jusufovic R; Horozic D; Lekic L; Tabakovic V
    Med Arch; 2019 Oct; 73(5):351-355. PubMed ID: 31819310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of diabetes indices of care by a short pharmaceutical care program.
    Turnacilar M; Sancar M; Apikoglu-Rabus S; Hursitoglu M; Izzettin FV
    Pharm World Sci; 2009 Dec; 31(6):689-95. PubMed ID: 19777365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of steady-dose metformin in type 2 diabetes mellitus: a retrospective study.
    Drzewoski J; Czupryniak L
    Med Sci Monit; 2003 Jun; 9(6):CR240-3. PubMed ID: 12824953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycaemic control in type 2 diabetes.
    Campbell A
    Clin Evid; 2005 Dec; (14):474-90. PubMed ID: 16620416
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of a Community Pharmacist-Delivered Information Program on the Follow-up of Type-2 Diabetic Patients: A Cluster Randomized Controlled Study.
    Michiels Y; Bugnon O; Chicoye A; Dejager S; Moisan C; Allaert FA; Hunault C; Romengas L; Méchin H; Vergès B
    Adv Ther; 2019 Jun; 36(6):1291-1303. PubMed ID: 31049873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.
    Umpierrez G; Issa M; Vlajnic A
    Curr Med Res Opin; 2006 Apr; 22(4):751-9. PubMed ID: 16684436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
    Mamza J; Mehta R; Donnelly R; Idris I
    Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of type 2 diabetic patients.
    Dailey G; Kim MS; Lian JF
    J Int Med Res; 2002; 30(1):71-9. PubMed ID: 11921502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes in primary care in belgium: need for structured shared care.
    Goderis G; Borgermans L; Heyrman J; Broeke CV; Grol R; Boland B; Mathieu C
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):367-72. PubMed ID: 19358093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.